Guggenheim on Forte Biosciences Inc. (FBRX): readout has 'highly favorable' risk/reward, set for +200% move
Guggenheim analyst Yatin Suneja reiterated a Buy rating and $75.00 price target on Forte Biosciences Inc. (NASDAQ: FBRX)The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)